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ABSTRACT 
Madsen, T. E., Khoury, J. C., Alwell, K. A., Moomaw, C. J., Demel, S. L., Flaherty, M. L., Woo, D., Mackey, J., De Los 
Rios La Rosa, F., Martini, S., Ferioli, S., Adeoye, O., Khatri, P., Kissela, B. M. and Kleindorfer, D. (), Sex Differences 
in Cardiovascular Risk Profiles of Ischemic Stroke Patients with Diabetes in the Greater Cincinnati/ Northern 
Kentucky Stroke Study. Journal of Diabetes. Accepted Author Manuscript. 
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We aimed to compare sex-specific associations between cardiovascular risk factors and diabetes 
mellitus (DM) among patients with acute ischemic stroke (AIS) in the Greater Cincinnati/Northern 
Kentucky Stroke Study (GCNKSS).   
Methods:  
The GCNKSS ascertained AIS cases in 2005 and 2010 among adult (age ≥20 years) residents of a 
biracial population of 1.3 million. Past and current stroke risk factors were compared between those 
with and without DM using chi-square and multiple logistic regression to examine sex-specific profiles.  
Results:   
There were 3515 patients with incident AIS; 1919 (55%) were female, 697 (20%) were black, and 
1146 (33%) had DM. Among both women and men with DM, significantly more were obese, and had 
hypertension, high cholesterol, and coronary artery disease (CAD) compared with those without DM. For 
women with AIS, in multivariable sex-specific adjusted analyses, older age was associated with a 
decreased odds of having DM (aOR=0.88, 95%CI 0.80-0.98). For women with CAD, the odds of DM were 
increased (aOR=1.76, 95%CI 1.33-2.32).  Age and CAD were not significant factors in differentiating the 
profiles of men with and without DM. 
Conclusions:   
Women with DM had strokes at a younger age, whereas no such age difference existed in men. 
As opposed to men, women with DM were also more likely to have CAD compared with those without 
DM, suggesting a sex difference in the association between DM and vascular disease. These findings may 
suggest a need for more aggressive risk factor management in diabetic women.  
 
Keywords: stroke, diabetes, sex differences, risk factors 
Highlights:  
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Among patients with incident ischemic stroke in the Greater Cincinnati Northern Kentucky 
Stroke Study, younger women and women with coronary artery disease (CAD) were more likely to have 
diabetes, whereas these associations were not significant for men.  Our findings suggest that there is a 
sex-specific association between younger age and incident strokes in women with diabetes; as a 
consequence, women with diabetes may benefit from more aggressive risk factor control. 
 
 
Introduction: 
Diabetes mellitus (DM) is a major risk factor for ischemic stroke; risk of stroke is 2 to 6 times 
higher for those with diabetes compared with those without diabetes and increases with the duration of 
diabetes.1–5 In addition, data suggest that the overall prevalence of DM, as well as the prevalence of DM 
in stroke patients, has been increasing over time and will continue to rise.2,6  
 For women in particular, DM has been classified as a risk factor equivalent to prior stroke in 
non-diabetics.7 Previous analyses comparing women and men directly have shown that the risk of 
incident ischemic stroke among patients with DM is greater in women than in men,8 and sex-stratified 
analyses have reported a higher incidence of ischemic stroke among diabetics in women compared with 
men overall and over time.9 This parallels results that have shown that diabetes is a stronger risk factor 
for coronary artery disease (CAD) for women compared with men.10,11 A meta-analysis that pooled data 
from 64 cohorts and reported sex-specific estimates of the relative risk (RR) of ischemic stroke in those 
with DM compared with those without DM reported a RR of 2.28 for women, compared with 1.83 for 
men. The risk of stroke in this study for diabetic women was 27% higher than for diabetic men when 
direct sex comparisons were performed.8 Possible factors that may lead to sex differences in the risk of 
ischemic stroke among diabetics include differences in the treatment or severity of DM, sex differences 
in the mechanism by which DM leads to cerebrovascular disease, or a sex difference in the risk factor 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
 
 
profile between women and men. For example, it may be that women with DM have an overall worse 
risk factor profile than men with DM.  
Objective 
Our study objective was to compare sex-specific associations between cardiovascular risk 
factors and diabetes mellitus (DM) among patients with acute ischemic stroke (AIS) in the Greater 
Cincinnati/Northern Kentucky Stroke Study (GCNKSS).  
Methods: 
Study Population  
 This is a cross-sectional study of patients with incident ischemic stroke in the Greater Cincinnati 
Northern Kentucky Stroke Study (GCNKSS). The GCNKSS is a population-based dataset comprised of 
stroke patients from a biracial population of approximately 1.3 million people residing in a 5-county 
region of southern Ohio and northern Kentucky.  This biracial population is representative of the United 
States population in terms of age, percent of people that are black, household income, level of 
education completed, and proportion of people below the poverty line. Cases of stroke among residents 
of these 5 counties are ascertained for a full calendar year every 5 years. Potential stroke cases are 
identified using discharge ICD-9 codes 430–436 from all acute-care hospitals in the study region. Data 
for each case is abstracted by study nurses and then reviewed by trained study physicians using a 
combination of clinical and imaging data to verify whether the case represents an acute stroke. Cases of 
stroke are also ascertained from local outpatient clinics, from county coroner data, and from a random 
sample of primary care doctors and nursing homes. Further details of the GCKNSS methodologies, 
including case definition and ascertainment have been previously published.12,13 For the present study, 
only adults (age of 20 years or greater) with incident ischemic stroke occurring in calendar years 2005 or 
2010 were included for analysis. The two time periods (2005 and 2010) are cross-sectional incident 
populations and were analyzed together. Ascertainment methods and case definition were consistent 
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over the two time periods. The institutional review board at each participating hospital approved the 
study. 
Data collection  
 Data regarding patients’ demographic characteristics (age and race) as well as history of DM and 
cardiovascular risk factors were obtained from patient medical records by trained study nurses. In order 
to be categorized as having DM, there must have been documentation of DM as a medical problem prior 
to the incident stroke event. Patients with undiagnosed diabetes were categorized as not having DM for 
the purposes of this study. Risk factors obtained from documented medical history in patients’ charts 
included prior diagnoses of hypertension, high cholesterol, coronary artery disease (CAD), myocardial 
infarction (MI), atrial fibrillation, and current smoking status. For hypertension, patients had to have a 
documented medical history of hypertension to be counted in this category. Elevated cholesterol was 
defined as a prior history of elevated total cholesterol or LDL; terms including hyperlipidemia, 
hypercholesterolemia, and dyslipidemia were included in this definition.  History of CAD was defined as 
prior myocardial infarct, CABG, coronary angioplasty/stenting, or unstable angina. Atrial fibrillation was 
defined as having been diagnosed with atrial fibrillation in the past or being in atrial fibrillation on 
admission. Current smoker was defined as any cigarette smoking in the last 3 months. Height and weight 
were abstracted from the patient chart to calculate BMI. In addition to analysis as a continuous variable, 
obesity was treated as a binary variable, with obese defined as BMI≥30 kg/m2.” Reported medications 
prior to the stroke event were also abstracted from patient charts and categorized into lipid lowering 
medications, anti-hypertensive medications, anticoagulants, and aspirin (ASA)/ antiplatelet agents.  
Statistical analysis 
 First, the study population was described in terms of baseline characteristics: age, black race, 
and history of DM. These characteristics were compared between women and men using t-test for age 
and chi-square for black race and history of diabetes. Bivariate analyses were used to compare mean 
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age, the proportion of patients with age >65 years, body mass index (BMI), BMI ≥ 30kg/m2, and each of 
the pre-specified cardiovascular risk factors in sex-specific analyses (women with DM compared with 
women without DM, men with DM compared with men without DM). The risk factors including history 
of hypertension, high cholesterol, CAD, myocardial infarction, atrial fibrillation, and current smoker vs. 
nonsmoker/former smoker were treated as binary variables. T-tests were used for the continuous 
variables of age and BMI, and chi-square tests were performed for the categorical variables, and 
associated p-values were reported.  Bonferroni corrections were applied due to multiple comparisons. 
Descriptive statistics (means and standard deviations or frequencies and proportions, as appropriate) 
were reported.  
Bivariate analyses were also used to compare medications reported on admission. Only 
medications listed as being taken prior to the stroke event were included. For each category of 
medications (lipid lowering medications, antihypertensive medications, ASA/ antiplatelet agents, and 
anticoagulants), proportions of women versus men were compared in each study period (2005, 2010). 
Frequencies, proportions, and p-values were reported. 
Following bivariate analyses, logistic regression was performed by sex to examine the sex-
specific odds of a patient with specific pre-defined cardiovascular risk factors having a pre-existing 
diagnosis of DM. The odds for each independent risk factor were adjusted for all other risk factors to 
account for potential clustering. Adjusted odds ratios (aOR) are reported. Further analyses involved a 
logistic regression including both women and men with diabetes as the dependent variable and the 
interaction of sex with each risk factor examined. Discriminant analysis was used to examine the 
clustering of the risk factors within the sex or diabetes groups. 
In all analyses, p-values < 0.05 were considered to be statistically significant. All analyses were 
performed using SAS® version 9.4 (SAS Institute, Cary, NC).  
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Results: 
 In total, 3515 patients with incident ischemic stroke were included in the analysis; 1919 (54.6%) 
were female, 697 (19.8%) were black, and 1146 (32.6%) had histories of DM. Women were older than 
men (72.0 ±15.0 years vs. 67.2 ±14.0 years, p<0.0001). Similar proportions of women and men were 
black (compared with white) (n=395, 20.6%, vs. n=302, 18.9%, p=0.22), and a similar proportion of men 
and women had a history of DM (n=627, 32.7%, vs. n=519, 32.5%, p=0.92).  
In unadjusted analyses (Table 1), higher proportions of women with DM were obese, black, and 
had hypertension, high cholesterol, and CAD, compared with women without DM. In similar 
comparisons, among men with DM, more were obese, had hypertension, high cholesterol, and CAD than 
men without DM. Proportions of patients with atrial fibrillation were similar between those with and 
without DM in both men and women. Women with DM were younger, on average, than women without 
DM (mean 70.7±13.4 vs. 72.7±15.7 years, p=0.006), whereas men with and without DM were similar in 
age (67.1±13.1 years vs. 67.2±14.5 years, p=0.87).  
In direct comparisons of risk factors between women with DM and men with DM, higher 
proportions of women were obese (48.7% vs. 42.7%, p=0.05) or black (28.6% vs. 22.4%, p=0.02) 
compared with men. Similar proportions of women and men had hypertension (91.6% vs. 89.4%, 
p=0.22), and a slightly higher proportion of men had CAD (44.7% vs. 40.4%, p=0.14) compared with 
women. 
 In adjusted analyses (Table 2), among ischemic stroke patients, for women, increasing age 
decreased the odds of having a pre-existing diagnosis of diabetes (aOR 0.88, 95%CI 0.80–0.98 for each 
10 year increase), whereas for men age was not a significant factor (aOR 0.99, 95%CI 0.89–1.10 for each 
10 year increase). Another sex difference was in the odds of having DM among those with CAD: women 
with CAD were more likely to have had a pre-existing diagnosis of DM (aOR 1.80, 95%CI 1.36–2.38), but 
men with CAD had similar odds of having had DM compared with those without CAD (aOR 1.26, 95%CI 
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0.94–1.68). When interaction terms were included in the model with diabetes as the dependent 
variable, the interaction term between sex and age had a p-value of 0.07, and the interaction term 
between sex and CAD had a p-value of 0.01. There were significant positive associations between BMI, 
black race, hypertension, high cholesterol and our dependent variable of DM in both women and men. 
Both men and women with MI and atrial fibrillation had similar odds of having DM compared with men 
and women without these risk factors. Finally, both men and women who were current smokers had 
lower odds of having DM compared with men and women who were not current smokers. In both sexes, 
the associations between hypertension or obesity and DM were higher than the associations between 
other cardiovascular risk factors and DM. 
 Examination using discriminant analysis showed that about 70% of the patients could be 
correctly categorized as having diabetes versus not having diabetes within the sex-specific groups using 
the chosen risk factors. This is consistent with the c-statistics from the multiple logistic regressions of 
0.74 and 0.71 for women and men, respectively.    
 With regard to medications on admission (Table 3), similar proportions of women and men were 
on anticoagulant medications in both study periods. More women than men were on ASA or other 
antiplatelet agents in 2005, but there was no difference by sex in 2010. More women were on 
antihypertensives in both study periods. Finally, a larger proportion of men were on medications for 
hyperlipidemia in 2005, but proportions were similar between women and men in 2010.  
Discussion: 
 Previous literature has reported sex differences in the association between DM and incident 
stroke;8,9 however, our study is novel in its sex-specific description of the cardiovascular risk profiles of 
men and women with DM among ischemic stroke patients. Though there were many similarities in the 
risk factors associated with DM in women compared with men, we did find some sex-specific differences 
in demographics and risk factors between patients with DM and those without DM: women with a pre-
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
 
 
existing diagnosis of DM were younger and more likely to have CAD compared with those without a 
diagnosis of DM, but differences were not significant for these risk factors in men.  
The younger age of women with DM suggests that in women, DM may lead to more rapid 
progression of cerebrovascular disease that ultimately results in stroke at younger ages. Though 
presumably DM leads to stroke earlier in life in both sexes, there was no significant age difference 
between men with and without DM in our study, suggesting that this may not be true to the same 
degree in men compared with women. It is possible that there are risk factors that are more important 
than DM for men with regard to stroke risk. The difference in mean ages between women with and 
without DM was about 3 years; if women with DM have strokes 3 years earlier than women without 
DM, this has the potential to lead to more years of long-term disability and higher societal cost. Reasons 
for this age difference are not clear, but one could theorize that there are differences in the treatment 
of DM or that changes in exposure to sex hormones over the lifespan affect the mechanism by which 
DM leads to vascular dysfunction and stroke.14 Future efforts should examine whether women with DM 
may warrant more aggressive control of their DM and/or of other cardiovascular risk factors in order to 
prevent stroke. Tight glycemic control has not clearly been shown to reduce stroke risk,1 but future 
research should examine whether such an approach could potentially be more effective for women than 
men.  
These data are also interesting in light of our previous analyses2,3 that conclude that the risk of 
stroke conferred by DM is greatest in patients less than 65 years and that ischemic stroke patients with 
DM are younger than those without DM. Based on the present study, this may be largely driven by 
women with DM. Data showing that women with DM were more likely to have CAD than women 
without DM is consistent with prior data showing that DM carries a greater risk of cardiovascular 
outcomes in women compared with men.10  
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 Of note, in both women and men, the odds of DM among current smokers were lower than in 
non-smokers or former smokers.  This conflicts with known evidence that smoking is a risk factor for 
diabetes.15 Reasons for our findings are unclear and could be confounded by the inclusion of patients 
with type 1 diabetes, as smoking is primarily a risk factor for type 2 diabetes.15 Interventions to promote 
smoking cessations should continue to be a priority among patients at risk for stroke. 
Our results regarding the high prevalence of hypertension, obesity, and high cholesterol in the 
stroke patients in our study also suggest a need for more effective interventions in both sexes. Since 
obesity is an important risk factor for both recurrent vascular events as well as other health outcomes, 
this result suggests that obesity should continue to be a major target for intervention among stroke 
patients, especially women.  Unfortunately, some trials of lifestyle interventions to reduce obesity have 
been less effective in women.16 In addition, when patients with and without DM were compared (both 
men and women), the associations between hypertension, obesity, and high cholesterol and DM were 
higher than associations for other risk factors including age, smoking status, atrial fibrillation, and 
history of myocardial infarction. Consistent with prior data, this suggests that among stroke patients, 
there is often clustering of DM with the additional risk factors9,17,18 that comprise metabolic syndrome.19  
Our study has some limitations. Because we did not include patients with undiagnosed DM, we 
may have underestimated the prevalence of DM. There may also be sex differences in undiagnosed DM 
of which we are not aware.  In addition, we were not able to separate patients with insulin-dependent 
diabetes from those with non-insulin dependent diabetes, and these patients may have important 
distinctions in their risk factor profiles.18 Finally, we were not able to assess whether there were sex 
differences in the level of control of DM cardiovascular risk factors including levels of hypertension, 
cholesterol, and triglycerides.10 Future studies should investigate potential sex differences in treatment, 
differences in disease severity, and duration of disease for DM and other risk factors. 
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Our study of sex differences in the demographics and risk factor profiles of stroke patients with 
DM adds to the current knowledge around stroke prevention strategies in women with DM, but further 
research is needed to better understand the relationship between DM and stroke in women.16 For 
example, it is unknown whether more aggressive control of DM and other cardiovascular risk factors like 
obesity and hypertension might benefit women by slowing down the progression of cerebrovascular 
disease and mediating the risk of stroke from DM. This is especially important given previous data 
showing women are less likely to meet blood pressure goals and that hypertensive diabetics are at an 
especially high risk for a primary cerebrovascular event.1,10,16 These data also reinforce the clustering of 
metabolic risk factors among patients with DM. In addition, future research should examine whether 
there are sex differences in the association between risk of recurrent stroke and DM as this could lead to 
sex-specific secondary stroke prevention strategies targeted at the treatment of DM and related 
vascular risk factors. A better understanding of both the overall and sex-specific risk factor profiles of 
patients with ischemic stroke and DM could lead to more effective and personalized primary and 
secondary stroke prevention strategies in diabetic patients.  
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Table 1: Sex-Specific Comparison of Stroke Risk Factors in Those With and Without Diabetes (DM) 
Stroke risk factor (n, %) Women 
with 
DM  
(n=627) 
Women 
without  
DM 
(n=1292) 
Men with 
DM 
(n= 519) 
Men 
without DM 
(n=1077) 
Age (years) 
mean (sd) 
70.7 (13.4)a 72.7 (15.7) 67.1 (13.1) 67.2 (14.5) 
BMI (kg/m2) 
mean (sd) 
30.8 (8.0)a 26.7 (6.9) 29.4 (6.5)b 27.0 (5.2) 
Age ≥ 65 years 427 (68.1%) 946 (73.2%) 293 (56.4%) 621 (57.7%) 
Obese 
BMI ≥ 30 kg/m2  
271 (48.7%)a 283 (25.3%) 201 (42.7%)b 209 (21.8%) 
Black race 179 (28.6%)a 216 (16.7%) 116 (22.4%) 186 (17.3%) 
Hypertension 574 (91.6%)a 950 (73.5%) 464 (89.4%)b 747 (69.4%) 
High cholesterol 360 (57.4%)a 447 (34.6%) 313 (60.3%)b 442 (41.0%) 
Coronary artery disease 
(CAD) 
253 (40.4%)a 299 (23.1%) 232 (44.7%)b 348 (32.3%) 
Myocardial infarction 
(MI) 
97 (15.5%)a 114 (8.8%) 100 (19.3%) 158 (14.7%) 
Atrial fibrillation 159 (25.4%) 347 (26.9%) 113 (21.8%) 220 (20.4%) 
Current smoker 113 (18.0%) 298 (23.1%) 126 (24.3%)b 362 (33.6%) 
a: p<0.05 in bivariate comparison between women with and without DM after Bonferroni correction. 
b: p<0.05 in bivariate comparison between men with and without DM after Bonferroni correction. 
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Table 2: Multivariable analysis by sex of having diabetes according to cardiovascular risk factors 
among ischemic stroke patients 
Stroke risk factor  Women 
aOR 
(95%CI) 
Men 
aOR 
(95%CI) 
 
Age  
(for each 10 year increase) 
0.88 
(0.80-0.98) 
0.99 
(0.89-1.10) 
BMI  
(for each 5 kg/m2 increase) 
1.36 
(1.25-1.48) 
1.36 
(1.22-1.52) 
Black race 1.81 
(1.37-2.39) 
1.42 
               (1.04-1.93) 
Hypertension 3.22 
(2.23-4.74) 
2.99 
(2.13-4.27) 
High cholesterol 1.96 
(1.55-2.48) 
1.65 
(1.28-2.13) 
Coronary artery disease (CAD) 1.80 
(1.36-2.38) 
1.26 
(0.94-1.68) 
Myocardial infarction (MI) 0.96 
(0.66-1.40) 
0.84 
(0.59-1.21) 
Atrial fibrillation 0.91 
(0.70-1.18) 
1.00 
(0.74-1.35) 
Current smoker 0.61 
(0.45-0.83) 
0.69 
(0.52-0.92) 
Notes: aOR: Odds of a patient with each risk factor having DM as a pre-existing condition; reference 
group for each sex is patients without the specified risk factor. Each OR has been adjusted for all other 
risk factors in table. Bold text indicates that adjusted odds ratios are statistically significant in women 
but not men. 
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Table 3: Medications on Admission by Study Period and Sex Among Adults with Ischemic Stroke in 
GCNKSS 
 
                                 2005                                 2010 
 Men Women Men Women 
Medications for 
Hyperlipidemia1 
287a 
(36.5%) 
288 
(30.8%) 
300 
(37.1%) 
400 
(40.7%) 
Antihypertensives2 537a 
(68.2%) 
709 
(75.8%) 
527b
(65.1%) 
756 
(76.9%) 
Anticoagulants3 89 
(11.3%) 
115 
(12.3%) 
93 
(11.5%) 
127 
(12.9%) 
ASA/ Antiplatelet 
Agents4 
343a 
(37.3%) 
349 
(43.6%) 
327 
(40.4%) 
410 
(41.7%) 
 
a: p<0.05 in bivariate comparison between women and men in 2005. 
b: p<0.05 in bivariate comparison between women and men in 2010. 
1: Medications for hyperlipidemia included statins and other lipid lowering medications. 2: 
Antihypertensive medications included ACE inhibitors, alpha 1 blockers, alpha II agonists, angiotensin II 
receptor blockers, beta blockers, calcium channel blockers, diuretics, vasodilating medications, and 
nitrates. 3: Anticoagulants included warfarin, heparin, enoxaparin, dalteparin, tinzaparin, and low 
molecular weight heparin, direct thrombin inhibitors, and factor Xa inhibitors. 4: ASA/ antiplatelet 
agents included aspirin, clopidogrel, eptifibatide, dipyridamole, cilostazol, ticlopidine, prasugrel, and 
anagrelide. 
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